Table 3.
O2 flow corrected for Rox | Overall sprinting | O2 flux corrected for Rox | Repeated sprinting | |||||||
---|---|---|---|---|---|---|---|---|---|---|
IO2 [amol·s-1·cell-1] | Δ De-oxygenation | Δ Re-oxygenation | JO2/CS [pmol·s-1·IU-1] | Δ Re-oxygenation | ||||||
before | after | Δ | TOI [%] | TOI [%] | before | after | Δ | [TOI%] | ||
RSH 1 | R | 5.1 | 4.0 | 1.17 | 1.31 | |||||
E | 23.4 | 13.7 | -9.7 | -9.7 | 12.82 | 5.39 | 4.43 | -0.96 | -2.9 | |
RSH 2 | R | 3.6 | 3.0 | 0.93 | 0.94 | |||||
E | 21.4 | 8.0 | -13.4 | -19.8 | 12.4 | 5.54 | 2.48 | -3.06 | 5.8 | |
SIH 1 | R | 2.9 | 4.9 | 1.08 | 1.37 | |||||
E | 16.8 | 16.0 | -0.7 | -2.3 | 7.7 | 6.34 | 4.49 | -1.86 | 2.9 | |
SIH 2 | R | 3.3 | 5.5 | 1.13 | 1.26 | |||||
E | 18.4 | 23.5 | 5.1 | 1.24 | -0.44 | 6.24 | 5.36 | -0.88 | -1.84 |
RSH1, RSH2 – participants with RSH training, SIH1, SIH2 – participants with SIH training. ROUTINE respiration (R) and electron transfer capacity (E) were determined as described in the methods section. IO2 – oxygen flow per cell count [amol·s-1·cell-1 = pmol·s-1·10-6 cells], JO2 – oxygen flux per mitochondrial marker citrate synthase activity [pmol·s-1·IU-1] 37. Respiration was corrected for the contribution from PLTs contaminating the PBMC fraction. Rox – residual oxygen consumption.